Developer docs
API playgroundTry for free, no card

Search company profiles

Pharma Mix

Full company profile

uuid003dp7x

Namestring
Pharma Mix
Legal namestring
PharmaMix
Websiteurl
pharmamix.org
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Pharma Mix (also operating as PharmaMix International, فارماميكس) is a privately held Egyptian pharmaceutical outsourcing and commercialization services company founded in 1999, headquartered at 17 El-Nakheel Street, Mohandessin, Giza. The company was established as a strategic outsourcing partner for Amoun Pharmaceuticals (آمون للأدوية), initially promoting an exclusive portfolio of six ophthalmology products, and has since expanded into a diversified therapeutic portfolio spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, cardiovascular, and nutritional supplement categories. Its core capability is outsourced pharmaceutical commercialization: a specialized medical sales force, physician-engagement platform, and market-access infrastructure that enables pharmaceutical principals to deploy and scale products in Egypt and select regional markets without building their own field operations. The company's product portfolio includes Cortiplex B6 Adult and Pediatric (adrenal cortex extract with pyridoxine injections), Solpadol (zolmitriptan orally disintegrating tablets for migraine), Angioblock and Angioblock Mono (irbesartan-based antihypertensives), Shamsomox (moxifloxacin), Coughsed Paracetamol (suppository), Patadoline (olopatadine ophthalmic), Ivybubble (herbal respiratory syrup), Citra Forte (potassium sodium hydrogen citrate granules), Escitapram (escitalopram), and dietary supplements Lactobay (lactoferrin with vitamin C) and Daline (cholecalciferol D3 drops).\n\nPharma Mix generates revenue primarily through managed-services arrangements with pharmaceutical principals, under which it provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management. Annual sales exceeded 680 million EGP as of July 2025, attributable to a managed portfolio of more than 25 ethical products for Amoun Pharmaceuticals. Distribution is handled through Egyptian pharmacy networks and direct field sales via medical representatives, with growing international presence through product registrations in UAE, Oman, and Uganda targeting broader expansion into Africa, GCC, Iraq, and CIS markets. Go-to-market combines enterprise field sales, event-driven engagement at medical conferences and scientific symposia (including the Arab Academy of Pediatrics Congress and Egyptian Urology Association Congress), and community-led training programs for pharmaceutical teams.\n\nThe company entered a strategic partnership with Global Napi (GNP) in 2025 to support international expansion, and operates with a headcount of 51–100 employees. It maintains a presence on LinkedIn, Instagram, and Facebook, and positions itself around ethical, performance-driven promotion, world-class standards, and long-term trust-based partnerships. Pharma Mix's stated vision is to rank among the top 80 pharmaceutical companies in Egypt by 2030 through strong outsourcing portfolios and strategic partnerships. The underlying technology stack is conventional — no proprietary AI, APIs, or platform technology is disclosed — and the moat is built on 25 years of accumulated distribution, regulatory familiarity, and physician relationships in the Egyptian pharmaceutical market rather than on technology differentiation.

Short descriptiontext

Pharma Mix is a privately held Egyptian pharmaceutical outsourcing firm providing brand planning, sales force management, and medical marketing services for pharmaceutical principals, managing a 25+ ethical-product portfolio primarily for Amoun Pharmaceuticals across Egypt and select MEA markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGîza, Egypt
HQ citystring
Gîza
HQ countrystring
Egypt
HQ regionstring
Africa
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical marketing, toll manufacturing, ethical pharmaceuticals, sales force management, pharmaceutical outsourcing
Industry2 codes
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYMPAAAAAJ
Healthcare/Pharma Creative Agencies
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Advertising Agencies (Full-Service/Creative)
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Outsourcing and Marketing Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Outsourcing Services
TypeManaged Services
Description

End-to-end outsourcing services for pharmaceutical companies including brand strategy planning, sales force management, medical marketing execution, market access coordination, and product lifecycle management. As of July 2025, annual sales exceeded 680 million EGP.

pharmamix.org
2Pharmaceutical Product Sales
TypeOne Time License
Description

Sale of proprietary pharmaceutical products across multiple therapeutic categories including ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional supplements. Portfolio expanded from 6 products in 1999 to over 25 ethical products and additional product lines.

pharmamix.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Supply Chain, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pharma Mix is a strategic pharmaceutical outsourcing partner that provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management for pharmaceutical companies in Egypt. Founded in 1999 as a marketing partner for Amoun Pharmaceuticals, the company has expanded to manage a portfolio of 25+ ethical pharmaceutical products and dietary supplements spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional categories, with additional toll manufacturing capabilities and international registrations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Annual sales exceeded 680 million EGP as of July 2025
+2 more records
Product overview1 text field

Pharma Mix operates as a pharmaceutical outsourcing and marketing services company established in 1999, offering a diversified portfolio of pharmaceutical products and dietary supplements. The product portfolio includes: Cortiplex B6 (Adult and Pediatric) corticosteroid injections, Solpadol migraine treatment, Angioblock and Angioblock Mono hypertension medications, Coughsed Paracetamol for cough relief, Shamsomox anti-microbial agent, Patadoline ophthalmic solution, Iv ybubble respiratory syrup, Citra Forte urinary system support, Escitapram for central nervous system conditions, and dietary supplements Lactobay (lactoferrin with vitamin C) and Daline (vitamin D3). The company organizes products across therapeutic categories including central nervous system, urinary system, respiratory system, ophthalmology, anti-microbial, dietary supplements/vitamins, and pediatric products.

Product and service13 records
1Cortiplex B6 Adult (كورتيبليكيس بي 6 للبالغين)
CategoryPharmaceutical Product - Corticosteroid Injection
Description

Corticosteroid extract 100 CDU equivalent to 300mcg hydrocortisone combined with pyridoxine hydrochloride 50mg, formulated as an intramuscular injection solution for adult use.

2Cortiplex B6 Pediatric (كورتيبليكيس بي 6 للأطفال)
CategoryPharmaceutical Product - Corticosteroid Injection
Description

Adrenal cortex extract 50 CDU equivalent to 150mcg hydrocortisone with pyridoxine hydrochloride 20mg, formulated as an intramuscular injection solution for pediatric use.

3Solpadol (سولبادول)
CategoryPharmaceutical Product - CNS / Migraine
Description

Zolmitriptan 2.5mg and 5mg formulated as orally disintegrating tablets (ODT) for migraine treatment.

4Angioblock (أنجيو بلوك)
CategoryPharmaceutical Product - Cardiovascular / Antihypertensive
Description

Fixed-dose combination of irbesartan with hydrochlorothiazide available in three strengths (150/12.5mg, 300/12.5mg, 300/25mg), formulated as film-coated tablets for hypertension management.

5Angioblock Mono (أنجيو بلوك مونو)
CategoryPharmaceutical Product - Cardiovascular / Antihypertensive
Description

Irbesartan monotherapy available in 75mg, 150mg, and 300mg tablet formulations for hypertension treatment.

6Coughsed Paracetamol (كوفسيد – باراسيتامول)
CategoryPharmaceutical Product - Respiratory / Cough Relief
Description

Combination of gelseomium extract, grindelia extract, and paracetamol formulated as suppositories for cough relief.

7Shamsomox (شمسوموكس)
CategoryPharmaceutical Product - Anti-microbial
Description

Moxifloxacin 400mg formulated as film-coated tablets, an anti-microbial agent for treating bacterial infections.

8Patadoline (باتادولين)
CategoryPharmaceutical Product - Ophthalmology
Description

Olopatadine 0.1% ophthalmic solution for eye care, providing relief from allergic eye conditions.

9Ivybubble (ايفاي بابل)
CategoryPharmaceutical Product - Respiratory
Description

Herbal respiratory syrup combining ivy leaf extract (35mg), thyme extract (21.5mg), and licorice extract (21.7mg) per 5ml, supporting respiratory health and relieving cough.

10Citra Forte (سيترافورت)
CategoryPharmaceutical Product - Urinary System
Description

Potassium sodium hydrogen citrate in granule form for urinary system support and alkalization.

11Escitapram (اسيتابرام)
CategoryPharmaceutical Product - CNS / Antidepressant
Description

Escitalopram 10mg and 20mg tablets for the treatment of central nervous system conditions including depression and anxiety disorders.

12Lactobay (لاكتوباي)
CategoryDietary Supplement - Vitamins and Nutrition
Description

Lactoferrin 100mg with vitamin C 40mg in sachet format, supporting immune function and iron absorption.

13Daline (دالين)
CategoryDietary Supplement - Vitamins and Nutrition
Description

Cholecalciferol (Vitamin D3) 400 IU per drop in oral drop format, supporting bone health and immune system function, with coconut oil base for enhanced absorption.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Global Napi (GNP)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

PharmaMix entered a strategic partnership with Global Napi (GNP) as part of its expansion strategy, with plans to build additional strategic alliances during the upcoming period. This represents a significant partnership for international market expansion.

pharmamix.org
2Amoun Pharmaceuticals (آمون للأدوية)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1999-01-01
Description

PharmaMix was founded in 1999 as a strategic outsourcing partner for Amoun Pharmaceuticals, exclusively promoting a specialized portfolio of ophthalmology products. This partnership established one of the most successful long-term outsourcing models in the local pharmaceutical sector, expanding from 6 products to 25+ ethical products across multiple therapeutic areas. The partnership continues as of July 2025.

pharmamix.org
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Eva Pharma
TypeDirect peer
Description

Major Egyptian pharmaceutical manufacturer and marketer with broad therapeutic-area coverage and integrated distribution across Egypt and select MENA/African markets. Directly comparable as an Egypt-anchored pharma company combining manufacturing, marketing and distribution like PharmaMix.

2EIPICO (Egyptian International Pharmaceutical Industries Company)
TypeDirect peer
Description

One of Egypt's largest pharmaceutical manufacturers with diversified therapeutic portfolio and established sales force across Egyptian pharmacies. Comparable as a domestically-focused pharma peer competing for the same HCP and pharmacy channel.

3Pharco Pharmaceuticals
TypeDirect peer
Description

Largest Egyptian pharmaceutical company by domestic sales with extensive product portfolio, manufacturing and distribution infrastructure. Closest scale peer in the Egyptian pharma market, similarly combining manufacturing with broad pharmacy-channel commercialization.

4Global Napi Pharmaceuticals (GNP)
TypeDirect peer
Description

Egyptian pharma manufacturer that entered a strategic 2025 partnership with PharmaMix. Operates across multiple therapeutic areas and competes for the same outsourced sales/marketing engagements; comparable as both peer and counterparty.

5Amoun Pharmaceuticals
TypeOthers
Description

PharmaMix's anchor outsourcing client since 1999 and a major Egyptian pharma manufacturer. Functions as a customer rather than direct competitor, but is structurally the most relevant counterparty shaping PharmaMix's revenue base.

6Hikma Pharmaceuticals
TypeBroad incumbent
Description

Jordan-headquartered global pharma company with significant MENA manufacturing, branded generics and distribution footprint. Comparable as a broader incumbent operating across the same regional markets PharmaMix is targeting.

7Julphar (Gulf Pharmaceutical Industries)
TypeRegional player
Description

UAE-based pharmaceutical manufacturer with GCC and emerging-markets distribution. Comparable as a regional peer for PharmaMix's UAE/Oman expansion plans and for its branded-generics + outsourcing-style commercial model.

8SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation)
TypeRegional player
Description

Saudi Arabia's largest pharmaceutical manufacturer with regional distribution across MENA. Comparable as a regional peer for PharmaMix's stated GCC expansion and for combining manufacturing with outsourced commercial functions.

9Aspen Pharmacare
TypeEmerging player
Description

Africa's largest pharmaceutical manufacturer with broad therapeutic coverage and active distribution across Sub-Saharan and MENA markets. Comparable as a peer relevant to PharmaMix's African expansion roadmap (Uganda registered).

10Tabuk Pharmaceuticals
TypeRegional player
Description

Saudi-based pharma manufacturer with branded generics and MENA distribution footprint, including GCC and selective African markets. Comparable as a regional peer relevant to PharmaMix's stated GCC and Africa expansion.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharma Mix

Pharmaceutical Outsourcing and Marketing Servicespharmamix.org

Pharma Mix is a privately held Egyptian pharmaceutical outsourcing firm providing brand planning, sales force management, and medical marketing services for pharmaceutical principals, managing a 25+ ethical-product portfolio primarily for Amoun Pharmaceuticals across Egypt and select MEA markets.

What Pharma Mix does

Pharma Mix (also operating as PharmaMix International, فارماميكس) is a privately held Egyptian pharmaceutical outsourcing and commercialization services company founded in 1999, headquartered at 17 El-Nakheel Street, Mohandessin, Giza. The company was established as a strategic outsourcing partner for Amoun Pharmaceuticals (آمون للأدوية), initially promoting an exclusive portfolio of six ophthalmology products, and has since expanded into a diversified therapeutic portfolio spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, cardiovascular, and nutritional supplement categories. Its core capability is outsourced pharmaceutical commercialization: a specialized medical sales force, physician-engagement platform, and market-access infrastructure that enables pharmaceutical principals to deploy and scale products in Egypt and select regional markets without building their own field operations. The company's product portfolio includes Cortiplex B6 Adult and Pediatric (adrenal cortex extract with pyridoxine injections), Solpadol (zolmitriptan orally disintegrating tablets for migraine), Angioblock and Angioblock Mono (irbesartan-based antihypertensives), Shamsomox (moxifloxacin), Coughsed Paracetamol (suppository), Patadoline (olopatadine ophthalmic), Ivybubble (herbal respiratory syrup), Citra Forte (potassium sodium hydrogen citrate granules), Escitapram (escitalopram), and dietary supplements Lactobay (lactoferrin with vitamin C) and Daline (cholecalciferol D3 drops).\n\nPharma Mix generates revenue primarily through managed-services arrangements with pharmaceutical principals, under which it provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management. Annual sales exceeded 680 million EGP as of July 2025, attributable to a managed portfolio of more than 25 ethical products for Amoun Pharmaceuticals. Distribution is handled through Egyptian pharmacy networks and direct field sales via medical representatives, with growing international presence through product registrations in UAE, Oman, and Uganda targeting broader expansion into Africa, GCC, Iraq, and CIS markets. Go-to-market combines enterprise field sales, event-driven engagement at medical conferences and scientific symposia (including the Arab Academy of Pediatrics Congress and Egyptian Urology Association Congress), and community-led training programs for pharmaceutical teams.\n\nThe company entered a strategic partnership with Global Napi (GNP) in 2025 to support international expansion, and operates with a headcount of 51–100 employees. It maintains a presence on LinkedIn, Instagram, and Facebook, and positions itself around ethical, performance-driven promotion, world-class standards, and long-term trust-based partnerships. Pharma Mix's stated vision is to rank among the top 80 pharmaceutical companies in Egypt by 2030 through strong outsourcing portfolios and strategic partnerships. The underlying technology stack is conventional — no proprietary AI, APIs, or platform technology is disclosed — and the moat is built on 25 years of accumulated distribution, regulatory familiarity, and physician relationships in the Egyptian pharmaceutical market rather than on technology differentiation.

Pharma Mix firmographics

Firmographics
Name
Pharma Mix
Legal name
PharmaMix
Website
https://pharmamix.org
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
101–250 employees
Short description
Pharma Mix is a privately held Egyptian pharmaceutical outsourcing firm providing brand planning, sales force management, and medical marketing services for pharmaceutical principals, managing a 25+ ethical-product portfolio primarily for Amoun Pharmaceuticals across Egypt and select MEA markets.
Ownership category
akta.pro rank

Pharma Mix industry classification

Industry
Product category
Pharmaceutical Outsourcing and Marketing Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYMPAAAAAJ
Healthcare/Pharma Creative Agencies
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Advertising Agencies (Full-Service/Creative)

Keywords

  • Pharmaceutical marketing
  • Toll manufacturing
  • Ethical pharmaceuticals
  • Sales force management
  • Pharmaceutical outsourcing

Where Pharma Mix is headquartered

Location

Headquarters

HQ city
Gîza
HQ country
Egypt
HQ region
Africa

Offices1 record

Markets served

Pharma Mix business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. Pharmaceutical Outsourcing Services: End-to-end outsourcing services for pharmaceutical companies including brand strategy planning, sales force management, medical marketing execution, market access coordination, and product lifecycle management. As of July 2025, annual sales exceeded 680 million EGP.
  2. Pharmaceutical Product Sales: Sale of proprietary pharmaceutical products across multiple therapeutic categories including ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional supplements. Portfolio expanded from 6 products in 1999 to over 25 ethical products and additional product lines.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Pharma Mix product offering

Product offering

Core offering

Pharma Mix is a strategic pharmaceutical outsourcing partner that provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management for pharmaceutical companies in Egypt. Founded in 1999 as a marketing partner for Amoun Pharmaceuticals, the company has expanded to manage a portfolio of 25+ ethical pharmaceutical products and dietary supplements spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional categories, with additional toll manufacturing capabilities and international registrations.

Product overview

Pharma Mix operates as a pharmaceutical outsourcing and marketing services company established in 1999, offering a diversified portfolio of pharmaceutical products and dietary supplements. The product portfolio includes: Cortiplex B6 (Adult and Pediatric) corticosteroid injections, Solpadol migraine treatment, Angioblock and Angioblock Mono hypertension medications, Coughsed Paracetamol for cough relief, Shamsomox anti-microbial agent, Patadoline ophthalmic solution, Iv ybubble respiratory syrup, Citra Forte urinary system support, Escitapram for central nervous system conditions, and dietary supplements Lactobay (lactoferrin with vitamin C) and Daline (vitamin D3). The company organizes products across therapeutic categories including central nervous system, urinary system, respiratory system, ophthalmology, anti-microbial, dietary supplements/vitamins, and pediatric products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cortiplex B6 Adult (كورتيبليكيس بي 6 للبالغين) Corticosteroid extract 100 CDU equivalent to 300mcg hydrocortisone combined with pyridoxine hydrochloride 50mg, formulated as an intramuscular injection solution for adult use.
  • Cortiplex B6 Pediatric (كورتيبليكيس بي 6 للأطفال) Adrenal cortex extract 50 CDU equivalent to 150mcg hydrocortisone with pyridoxine hydrochloride 20mg, formulated as an intramuscular injection solution for pediatric use.
  • Solpadol (سولبادول) Zolmitriptan 2.5mg and 5mg formulated as orally disintegrating tablets (ODT) for migraine treatment.
  • Angioblock (أنجيو بلوك) Fixed-dose combination of irbesartan with hydrochlorothiazide available in three strengths (150/12.5mg, 300/12.5mg, 300/25mg), formulated as film-coated tablets for hypertension management.
  • Angioblock Mono (أنجيو بلوك مونو) Irbesartan monotherapy available in 75mg, 150mg, and 300mg tablet formulations for hypertension treatment.
  • Coughsed Paracetamol (كوفسيد – باراسيتامول) Combination of gelseomium extract, grindelia extract, and paracetamol formulated as suppositories for cough relief.
  • Shamsomox (شمسوموكس) Moxifloxacin 400mg formulated as film-coated tablets, an anti-microbial agent for treating bacterial infections.
  • Patadoline (باتادولين) Olopatadine 0.1% ophthalmic solution for eye care, providing relief from allergic eye conditions.
  • Ivybubble (ايفاي بابل) Herbal respiratory syrup combining ivy leaf extract (35mg), thyme extract (21.5mg), and licorice extract (21.7mg) per 5ml, supporting respiratory health and relieving cough.
  • Citra Forte (سيترافورت) Potassium sodium hydrogen citrate in granule form for urinary system support and alkalization.
  • Escitapram (اسيتابرام) Escitalopram 10mg and 20mg tablets for the treatment of central nervous system conditions including depression and anxiety disorders.
  • Lactobay (لاكتوباي) Lactoferrin 100mg with vitamin C 40mg in sachet format, supporting immune function and iron absorption.
  • Daline (دالين) Cholecalciferol (Vitamin D3) 400 IU per drop in oral drop format, supporting bone health and immune system function, with coconut oil base for enhanced absorption.

Quantifiable outcome

  • Annual sales exceeded 680 million EGP as of July 2025
  • +2 more outcomes

Companies that use Pharma Mix

Customer profile

Segments2 records

Ideal customer profiles2 records

Pharma Mix technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pharma Mix partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • Global Napi (GNP)flagshipStrategic or Co-development Partner · 1 January 2025PharmaMix entered a strategic partnership with Global Napi (GNP) as part of its expansion strategy, with plans to build additional strategic alliances during the upcoming period. This represents a significant partnership for international market expansion.
  • Amoun Pharmaceuticals (آمون للأدوية)coreStrategic or Co-development Partner · 1 January 1999PharmaMix was founded in 1999 as a strategic outsourcing partner for Amoun Pharmaceuticals, exclusively promoting a specialized portfolio of ophthalmology products. This partnership established one of the most successful long-term outsourcing models in the local pharmaceutical sector, expanding from 6 products to 25+ ethical products across multiple therapeutic areas. The partnership continues as of July 2025.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Pharma Mix competitors and assessment

Company assessment

Direct peers

  • Eva Pharma: Major Egyptian pharmaceutical manufacturer and marketer with broad therapeutic-area coverage and integrated distribution across Egypt and select MENA/African markets. Directly comparable as an Egypt-anchored pharma company combining manufacturing, marketing and distribution like PharmaMix.
  • EIPICO (Egyptian International Pharmaceutical Industries Company): One of Egypt's largest pharmaceutical manufacturers with diversified therapeutic portfolio and established sales force across Egyptian pharmacies. Comparable as a domestically-focused pharma peer competing for the same HCP and pharmacy channel.
  • Pharco Pharmaceuticals: Largest Egyptian pharmaceutical company by domestic sales with extensive product portfolio, manufacturing and distribution infrastructure. Closest scale peer in the Egyptian pharma market, similarly combining manufacturing with broad pharmacy-channel commercialization.
  • Global Napi Pharmaceuticals (GNP): Egyptian pharma manufacturer that entered a strategic 2025 partnership with PharmaMix. Operates across multiple therapeutic areas and competes for the same outsourced sales/marketing engagements; comparable as both peer and counterparty.

Others

  • Amoun Pharmaceuticals: PharmaMix's anchor outsourcing client since 1999 and a major Egyptian pharma manufacturer. Functions as a customer rather than direct competitor, but is structurally the most relevant counterparty shaping PharmaMix's revenue base.

Broad incumbents

  • Hikma Pharmaceuticals: Jordan-headquartered global pharma company with significant MENA manufacturing, branded generics and distribution footprint. Comparable as a broader incumbent operating across the same regional markets PharmaMix is targeting.

Regional players

  • Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with GCC and emerging-markets distribution. Comparable as a regional peer for PharmaMix's UAE/Oman expansion plans and for its branded-generics + outsourcing-style commercial model.
  • SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Saudi Arabia's largest pharmaceutical manufacturer with regional distribution across MENA. Comparable as a regional peer for PharmaMix's stated GCC expansion and for combining manufacturing with outsourced commercial functions.
  • Tabuk Pharmaceuticals: Saudi-based pharma manufacturer with branded generics and MENA distribution footprint, including GCC and selective African markets. Comparable as a regional peer relevant to PharmaMix's stated GCC and Africa expansion.

Emerging players

  • Aspen Pharmacare: Africa's largest pharmaceutical manufacturer with broad therapeutic coverage and active distribution across Sub-Saharan and MENA markets. Comparable as a peer relevant to PharmaMix's African expansion roadmap (Uganda registered).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Pharma Mix social profiles

Digital presence

Pharma Mix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharma Mix leadership team

Management profile

Number of profiles

Pharma Mix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharma Mix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Mix

What does Pharma Mix do?

Pharma Mix is a strategic pharmaceutical outsourcing partner that provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management for pharmaceutical companies in Egypt. Founded in 1999 as a marketing partner for Amoun Pharmaceuticals, the company has expanded to manage a portfolio of 25+ ethical pharmaceutical products and dietary supplements spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional categories, with additional toll manufacturing capabilities and international registrations.

Is Pharma Mix a public or private company?

Pharma Mix is a private company. It is classified as unknown and is currently operating.

When was Pharma Mix founded?

Pharma Mix was founded in 1999. It employs 101 to 250 people.

Where is Pharma Mix based?

Pharma Mix is headquartered in Gîza, Egypt, in the Africa region.

How does Pharma Mix make money?

Two revenue lines are on record. Pharmaceutical Outsourcing Services are the primary driver. The others are pharmaceutical Product Sales.

Who are Pharma Mix's main competitors?

Direct peers on record are Eva Pharma, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals and Global Napi Pharmaceuticals (GNP). Amoun Pharmaceuticals is listed as an others. Hikma Pharmaceuticals is listed as a broad incumbent. Regional players are Julphar (Gulf Pharmaceutical Industries), SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation) and Tabuk Pharmaceuticals. Aspen Pharmacare is listed as an emerging player.

Does Pharma Mix have an API?

No public API is recorded for Pharma Mix.

What industry is Pharma Mix in?

Pharma Mix's product category is Pharmaceutical Outsourcing and Marketing Services. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of MPAAAAAJ, Healthcare/Pharma Creative Agencies. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales